The average number of patients evaluated to obtain the approval was 159.https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2780442 …
Show this thread
FDA approvals of 18 cancer drugs in 2020 tell you all you need to know about the hypocrisy, sophistry, double standards and ulterior motives applied to repurposed drugs. It also raises the question of the integrity of the scientific community fixated on large RCT-only evidence.pic.twitter.com/z9T18a0Rjw
-
-
Thanks. Twitter will use this to make your timeline better. UndoUndo
-
-
-
DEUX POIDS, DEUX MESURES
Thanks. Twitter will use this to make your timeline better. UndoUndo
-
-
-
Gee, wonder if these fast-track drug approvals have anything to do with the likely exploding demand for them in 2022 after a couple years of preventative neglect.
-
That would be reality soon.
End of conversation
New conversation -
-
-
"evidence based" has become a meaningless buzzword co-opted by the marketing departments.https://youtu.be/A3YB59EKMKw
Thanks. Twitter will use this to make your timeline better. UndoUndo
-
-
-
This change in mindset and opening of eyes of many medical proffesionals to the malfeasance if the pharma companies and erroneous or deliberately limited way to gather info/data, will be the best things to come out of the pandemic.
Thanks. Twitter will use this to make your timeline better. UndoUndo
-
-
-
I remember Pr Raoult in France saying just that at an IHUMarseile conference.
-
Lobby and corruption, that is the main problem of our modern days!
End of conversation
New conversation -
-
Show additional replies, including those that may contain offensive content
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.